Curatis Holding AG and Curatis AG completed a business combination on April 25, 2024, raising CHF4.36m.
Kinarus Therapeutics Holding AG, now renamed to Curatis Holding AG, and Curatis AG completed their business combination on April 25, 2024. The first trading day of the combined Curatis Group (CURN.SW) was on April 26. The transaction raised CHF4.36m in cash during Q1 2024. Curatis Group, focused on orphan and ultra-orphan indications, is a new addition to healthcare company listings.
April 26, 2024
3 Articles